Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSvm Uk Emerg Regulatory News (SVM)

Share Price Information for Svm Uk Emerg (SVM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 63.00
Ask: 67.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.349%)
Open: 65.00
High: 65.00
Low: 65.00
Prev. Close: 65.00
SVM Live PriceLast checked at -
SVM UK Emerging Fund is an Investment Trust

To outperform the IA UK All Companies Sector Average Index on a total return basis from investments in smaller UK companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

30 Nov 2017 15:01

SVM UK Emerging Fund Plc - Half-year Report

SVM UK Emerging Fund Plc - Half-year Report

PR Newswire

London, November 30

SVM UK EMERGING FUND PLC(the “Fund”)

HALF YEARLY REPORT(FOR THE SIX MONTHS TO 30 SEPTEMBER 2017)

A copy of the Half Yearly Report will be available to download from the Manager’s website at www.svmonline.co.uk and a copy will shortly be available for inspection at the National Storage Mechanism at www.morningstar.co.uk/uk/nsm. Copies are also available at 7 Castle Street, Edinburgh EH2 3AH, the registered office of the Fund.

HIGHLIGHTS

Net asset value return of 14.2% compared to a 4.9% return for the IA UK All Companies Sector Average Index and 3.6% return for the FTSE All-Share Index. The share price rose 19.3%. Positive contributions from Fevertree Drinks, Burford Capital, Johnson Service Group and Watkin Jones. Since the current investment managers took on responsibility for the portfolio in September 2012, net asset value has gained 124.9% against a benchmark return of 55.6% The portfolio is focused on medium-sized and smaller growing businesses, where management can deliver growth via self-help. Net asset value gained 5.7% in October 2017 to 113.7p.

“Long term capital growth from investments in smaller UK companies. Its aim is to outperform the IA UK All Companies Sector Average Index on a total return basis”

Financial Highlights

Total Return Performance to 30 September 2017 6 months 3 years 5 Years10 Years
Net Asset Value+14.2%+65.2%+124.9%+50.5%
Share Price+15.6%+52.9%+95.0%-1.9%
Benchmark Index *+4.9%+29.7%+55.6%+4.0%

* The benchmark index for the Fund was changed to the IA UK All Companies Sector Average Index from 1 October 2013 prior to which the FTSE AIM Index was used.SVM UK EMERGING FUND plc

Half Yearly Report 2017

CHAIRMAN’S STATEMENT

After a weak start in April, the UK stockmarket made progress in the period under review. Medium sized and smaller companies outperformed the FTSE 100 Index. Over the six months to 30 September 2017, the Company’s net asset value increased by 14.2% to 107.6p per share, compared to a return of 4.9% in the benchmark index, the IA UK All Companies Sector Average Index (total return). Progress continued in October with the Company’s net asset value gaining a further 5.7% to 113.7p.

The strongest contributions to performance in the period under review were from Fevertree Drinks, Burford Capital, Johnson Service Group and Watkin Jones. These are growing businesses that operate with innovative strategies. Each has a business model that is scalable, with limited need for additional external capital. For example, Watkin Jones is a specialist property developer and manager, building student accommodation that it sells on to long term investing institutions. It also operates management contracts for the properties on behalf of insurers and pension funds. The main disappointment over the period was Hikma Pharmaceuticals.

During the six months, some profits were taken on investments in the gaming and property sectors. After strong performance, part of the gains in Fevertree Drinks and Micro Focus were also realised. Reinvestment was made in a number of medium sized growing businesses, including; Oxford Instruments, Gamma Communications, Polypipe Group, Sophos, Blue Prism and Moneysupermarket. New smaller company investments included Animalcare Group, Hotel Chocolat and Quixant, a gaming technology business. These portfolio changes increase the emphasis on specialist medium sized and smaller companies addressing growth markets. These businesses operate in niches, generally less exposed to price competition.

The British economy proved relatively resilient despite Brexit uncertainty. Many domestic companies have significant overseas earnings and were helped by the better economic performance of the global economy and, particularly, Continental Europe. UK inflation is higher, putting pressure on real wages, but the rise in employment numbers is maintaining consumption growth. The portfolio continues to have relatively low exposure to banks, oil and gas, and mining. We remain particularly concerned at the longer term outlook for banks and retailing, where there is the potential for disruption by newer business models. 

Although monetary policy is likely to tighten in the UK, we expect this to be measured and gradual. UK services show limited pick-up in inflation and sterling has recently been recovering against the US Dollar. This means that the inflation shock from last year’s devaluation may not become embedded in wage expectations. Your Managers meetings with investee companies still indicate favourable trading conditions. The portfolio emphasises exposure to scalable businesses with a competitive edge that can deliver above average growth. The Fund remains fully invested, making use of its ability to apply gearing to increase market exposure

SVM UK EMERGING FUND plc

Half Yearly Report 2017

INVESTMENT OBJECTIVE and POLICY

The investment objective of SVM UK Emerging Fund plc (the “Fund” or the “Company”) is long term capital growth from investments in smaller UK companies. Its aim is to outperform the IA UK All Companies Sector Average Index on a total return basis

The Fund aims to achieve its objective and to diversify risk by investing in shares and related instruments, controlled by a number of limits on exposures. Appropriate guidelines for the management of the investments, gearing and financial instruments have been established and are regularly reviewed by the Board. This is an abridged version of the Fund’s investment policy. The full investment policy can be found in the Strategic Report within the Fund’s latest Annual Report & Accounts.

DIRECTORS’ RESPONSIBILITY STATEMENT

The Directors are responsible for preparing the Half Yearly Report in accordance with applicable law and regulations.

The Directors confirm that to the best of their knowledge:

(i) the condensed set of financial statements have been prepared in accordance with the Financial Reporting Council Statement 104 “Interim Financial Reporting” on a going concern basis and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Fund;

(ii) the Half Yearly Report includes a fair review of the information required by the Disclosure and Transparency Rules DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and DTR 4.2.8R (disclosure of related party transactions and changes therein).

(iii) No related party transactions have taken place during the first six months of the year that have materially affected the financial position of the Fund during the period and there have been no changes in the related party transactions described in the Annual Report & Accounts for the year end 31 March 2017 that could do so.

The Directors consider that the Half Yearly Report, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Fund’s performance and strategy,

The Half Yearly Report has not been audited or reviewed by the Fund’s auditors.

By Order of the Board

Peter Dicks

Chairman

28 November 2017

SVM UK EMERGING FUND plc

Half Yearly Report 2017

UNAUDITED ACCOUNTS

Income Statement
Six months to 30 September 2017 Six months to 30 September 2016
RevenueCapitalTotalRevenueCapitalTotal
£’000£’000£’000£’000£’000£’000
Net gain on investments at fair value-753753-202202
Income 95-9585-85
Investment management fees------
Other expenses(32)(4)(36)(32)(4)(36)
Gain before finance costs and taxation 63 749 812 53 198 251
Finance costs(10)-(10)(9)-(9)
Gain on ordinary activities before taxation 53 749 802 44 198 242
Taxation------
Gain attributable to ordinary shareholders5374980244198242
Gain per Ordinary Share0.88p12.48p13.36p0.72p3.29p4.01p

The Total column of this statement is the profit and loss account of the Fund. All revenue and capital items are derived from continuing operations. No operations were acquired or discontinued in the year. A Statement of Comprehensive Income is not required as all gains and losses of the Fund have been reflected in the above statement. 
Year ended 31 March 2017 (audited)
RevenueCapitalTotal
£’000£’000£’000
Net gain on investments at fair value-717717
Income 138-138
Investment management fees---
Other expenses(64)(7)(71)
Gain before finance costs and taxation74710784
Finance costs(17)-(17)
Gain on ordinary activities before taxation57710767
Taxation1-1
Gain attributable to ordinary shareholders58710768
Gain per Ordinary Share0.96p11.82p12.78p

SVM UK EMERGING FUND plc

Half Yearly Report 2017

UNAUDITED ACCOUNTS

Balance Sheet
As at 30 September 2017 (unaudited)As at 31 March 2017 (audited)As at 30 September 2016 (unaudited)
£’000£’000£’000
Fixed Assets
Investments at fair value through profit or loss6,3075,5835,001
Total Current Assets382254333
Creditors: amounts falling due within one year(227)(177)(200)
Net current assets 15577133
Total assets less current liabilities6,4625,6605,134
Capital and Reserves6,4625,6605,134
Equity shareholders’ funds6,4625,6605,134
Net asset value per Ordinary Share107.61p94.25p85.48p

SVM UK EMERGING FUND plc

Half Yearly Report 2017

UNAUDITED ACCOUNTS

Statement of Changes in Equity
For the period to 30 September 2017
Share capitalShare premiumSpecial reserveCapital redemption reserveCapital reserveRevenue reserve
£’000£’000£’000£’000£’000£’000
As at 1 April 20173003145,14427311(436)
Gain attributable to shareholders----74953
As at 30 September 20173003145,144271,060(383)
For the year to 31 March 2017
Share  capitalShare  premiumSpecial reserveCapital redemption  reserveCapital reserveRevenue reserve
£’000£’000£’000£’000£’000£’000
As at 1 April 20163003145,14427(399)(494)
Gain attributable to shareholders----71058
As at 31 March 20173003145,14427311(436)
For the period to 30 September 2016
Share  capitalShare  premiumSpecial reserveCapital redemption  reserveCapital reserveRevenue reserve
£’000£’000£’000£’000£’000£’000
As at 1 April 20163003145,14427(399)(494)
Gain attributable to shareholders----19844
As at 30 September 20163003145,14427(201)(450)

SVM UK EMERGING FUND plc

Half Yearly Report 2017

UNAUDITED ACCOUNTS

Condensed Cash Flow Statement
Six months to 30 September 2017Year to 31 March 2017Six months to 30 September 2016
£’000 (unaudited)£’000 (audited)£’000 (unaudited)
Operating Activities Cash flow from operating activities 3 137 32
Taxation---
Investing Activities Purchases and sales of fixed asset investments 109 (229) (102)
Financing Activities Finance costs (10) (17) (9)
Movement in cash and cash equivalents 102(109)(79)
Cash and cash equivalents at start of period(7)102102
Cash and cash equivalents at end of period95(7)23

SVM UK EMERGING FUND plc

Half Yearly Report 2017

UNAUDITED ACCOUNTS

Investment Portfolio as at 30 September 2017
Stock Market Exposure 2017 £000 % of Net Assets Sector analysis as at 30 September 2017 Sector % of Gross Exposure
1Fevertree Drinks3174.9Consumer Services28.8
2Johnson Service Group 3104.8Consumer Goods20.1
34Imprint Group 2854.3Industrials15.2
4Eve Sleep*2764.3Financials12.7
5Burford Capital2564.0Healthcare11.5
6GVC Holdings2203.4Technology10.8
7Hutchison China Meditech1943.0Telecommunications0.9
8Redrow*1662.6Total100.0
9Supergroup*1612.5
10Unite Group1612.5
Ten largest investments2,34636.3
11ASOS1592.5
12FDM Group1582.4
13Kerry Group1502.3
14Beazley Group1502.3
15Workspace Group1472.3
16UDG Healthcare1392.2
17Ryanair1392.2
18Watkin Jones1312.0
19GB Group*1312.0
20JD Sports*1101.8
Twenty largest investments3,76058.3
21Eco Animal Health Group1131.7
22Hill & Smith1131.7
23Dechra Pharmaceuticals1101.7
24CVS Group1101.7
25Blue Prism1091.7
26Renishaw*1091.7
27Rentokil1081.7
28Premier Technical Services1071.7
29SSP Group1071.6
30Dotdigital1061.6
Thirty largest investments4,85275.1*Includes Contract for Difference (CFD) Market exposure for equity investments held is the same as fair value and for CFDs held is the market value of the underlying shares to which the portfolio is exposed via the contract.
Other investments (47 holdings)3,03446.9
Total investments7,886122.0
CFD positions exposure(1,792)(27.7)
CFD unrealised gains2133.3
Net current assets1552.4
Net assets6,462100.0

SVM UK EMERGING FUND plc

Half Yearly Report 2017

 UNAUDITED ACCOUNTS

Risks and Uncertainties

The principal risks facing the Fund relate to the investment in financial instruments and include market, liquidity, credit and interest rate risk. Additional risks faced by the Fund are investment strategy, share price discount, accounting, legal and regulatory, operational, corporate governance and shareholder relations, and financial. The Board seeks to mitigate and manage these risks through continuous review, policy setting and enforcement of contractual obligations. The Board receives both formal and informal reports from the Managers and third party service providers addressing these risks. An explanation of these risks and how they are mitigated is explained in the 2017 Annual Report, which is available on the Manager’s website: www.svmonline.co.uk. These principal risks and uncertainties have not changed from those disclosed in the 2017 Annual Report.

Going Concern

The Board, having made appropriate enquiries, has a reasonable expectation that the Fund has adequate resources to continue in operational existence for the foreseeable future, a period of not less than 12 months from the date of this report. Accordingly, it continues to adopt the going concern basis in preparing the financial statements.

Notes

1. The Financial Statements have been prepared on a going concern basis in accordance with

FRS 102 “Financial Reporting Standard applicable in the UK and Republic of Ireland”, FRS 104 “Interim Financial Reporting” and under the Association of Investment Companies Statement of Recommended Practice “Financial Statement of Investment Trust Companies and Venture Capital Trusts” issued in 2014, as were the interim financial statements for the period to 30 September 2016. These financial statements have been prepared in accordance with the accounting policies used for the financial year ended 31 March 2017.

2. Return per share is based on a weighted average of 6,005,000 (2016 – 6,005,000) ordinary shares in issue during the period.

Total return per share is based on the total gain for the period of £802,000 (2016 - gain of £242,000). Capital return per share is based on the capital gain for the period of £749,000 (2016 - gain of £198,000). Revenue return per share is based on the revenue gain after taxation for the period of £53,000 (2016 - gain of £44,000).

The number of shares in issue at 30 September 2017 was 6,005,000 (2016 - 6,005,000).

3. All investments are held at fair value. At 30 September 2017 no unlisted investments were held with value attributed (31 March 2017: same; 30 September 2016: same).

Investments have been classified using the fair value hierarchy:

September 2017 £000March 2017 £000
Classification of financial instruments
Level 16,0945,472
Level 2213111
Level 3 – 2 investments (March 2017 – 2)--

Level 1 reflects financial instruments quoted in an active market.

SVM UK EMERGING FUND plc

Half Yearly Report 2017

UNAUDITED ACCOUNTS

Level 2 reflects financial instruments whose fair value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets. The CFD positions are the sole Level 2 investments at 30 September 2017 and 31 March 2017

Level 3 reflects financial instruments whose fair value is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

4. The Board has granted the Manager a limited authority to invest in CFDs to achieve some degree of gearing and/or hedging without incurring the gross cost of the investment. The Board requires the Manager to operate within certain risk limits, as detailed in the Annual Report. The following table details the CFD positions:

Number of CFD holdings at 30 September 2017: 21 (31 March 2017: 16)

CFD positionsSeptember 2017March 2017
£000£000
Gross exposure1,7921,342
Net exposure1,7921,342
Unrealised gains213111
Unrealised losses216132

The gearing ratio is 24.0% at 30 September 2017 (31 March 2017: 23.8%). The gearing figure indicates the extra amount by which the shareholders’ funds would change if total assets (including CFD position exposure and netting off cash and cash equivalents) were to rise or fall. A figure of zero per cent means that the Company has a nil geared position.

5. The Manager has waived its fees for the periods to 30 September 2017 and 2016.

6. The above figures do not constitute full or statutory accounts in terms of Sections 434 and 435 of the Companies Act 2006. All information shown for the six months to 30 September 2017 is unaudited. The accounts for the year to 31 March 2017, on which the auditors issued an unqualified report, have been lodged with the Registrar of Companies and did not contain a statement required under Section 498 of the Companies Act 2006. 

For further information, please contact:

Colin McLean SVM Asset Management 0131 226 6699

Roland Cross Four Broadgate 0207 726 6111

Date   Source Headline
3rd Apr 20243:25 pmPRNQuarterly Disclosure
2nd Apr 20244:53 pmPRNNet Asset Value(s)
28th Mar 20249:22 amPRNHolding(s) in Company
22nd Mar 20244:54 pmPRNHolding(s) in Company
1st Mar 20244:29 pmPRNNet Asset Value(s)
1st Feb 20244:42 pmPRNNet Asset Value(s)
1st Feb 202412:00 pmPRNHolding(s) in Company
3rd Jan 202410:50 amPRNQuarterly Disclosure
2nd Jan 20244:30 pmPRNNet Asset Value(s)
1st Dec 20234:09 pmPRNNet Asset Value(s)
7th Nov 202310:27 amPRNHalf-year Report
1st Nov 20234:04 pmPRNNet Asset Value(s)
3rd Oct 20234:12 pmPRNQuarterly Disclosure
2nd Oct 20234:38 pmPRNNet Asset Value(s)
8th Sep 20239:22 amPRNResult of AGM
1st Sep 20233:51 pmPRNNet Asset Value(s)
1st Aug 20234:10 pmPRNNet Asset Value(s)
26th Jul 20231:57 pmPRNAnnual Financial Report March 2023
12th Jul 20231:07 pmPRNQuarterly Disclosure
5th Jul 20239:57 amPRNNet Asset Value(s)
1st Jun 20223:59 pmPRNNet Asset Value(s)
7th Apr 20224:36 pmPRNHolding(s) in Company
4th Apr 202212:43 pmPRNQuarterly Disclosure
1st Apr 20223:57 pmPRNNet Asset Value(s)
1st Mar 20224:12 pmPRNNet Asset Value(s)
1st Feb 20224:39 pmPRNNet Asset Value(s)
5th Jan 20222:07 pmPRNQuarterly Disclosure
4th Jan 20224:51 pmPRNNet Asset Value(s)
1st Dec 20213:59 pmPRNNet Asset Value(s)
8th Nov 202110:51 amPRNHalf-year Report
1st Nov 20214:18 pmPRNNet Asset Value(s)
4th Oct 20211:31 pmPRNQuarterly Disclosure
1st Oct 20214:26 pmPRNNet Asset Value(s)
10th Sep 202112:30 pmPRNResult of AGM
1st Sep 20214:01 pmPRNNet Asset Value(s)
2nd Aug 20214:19 pmPRNNet Asset Value(s)
14th Jul 20213:22 pmPRNAnnual Financial Report
5th Jul 202110:20 amPRNQuarterly Disclosure
1st Jul 20214:09 pmPRNNet Asset Value(s)
1st Jun 20214:17 pmPRNNet Asset Value(s)
10th May 20212:12 pmPRNHolding(s) in Company
4th May 20213:58 pmPRNNet Asset Value(s)
7th Apr 202110:37 amPRNQuarterly Disclosure
1st Apr 20214:20 pmPRNNet Asset Value(s)
1st Mar 20214:39 pmPRNNet Asset Value(s)
1st Feb 20214:57 pmPRNNet Asset Value(s)
5th Jan 20216:04 pmPRNQuarterly Disclosure - 05 January 2021
4th Jan 20214:30 pmPRNNet Asset Value(s)
1st Dec 20204:13 pmPRNNet Asset Value(s)
6th Nov 202012:11 pmPRNHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.